Tenofovir Disoproxil Fumarate Tablets IP 300Mg – GENTUZA 300 Tablets

GENTUZA 300 Tablets
Composition:- Tenofovir Fumarate 300mg

GENTUZA 300 Tablets – Tenofovir Disoproxil Fumarate Tablets IP 300 mg is a potent nucleotide reverse transcriptase inhibitor (NtRTI) indicated for the treatment of HIV-1 infection and chronic Hepatitis B (HBV). It works by inhibiting viral DNA synthesis, effectively reducing viral load, improving immune function, and slowing disease progression. Recognized globally as a first-line therapeutic agent, Tenofovir ensures sustained viral suppression with excellent long-term safety and efficacy profiles.

Key Points of Tenofovir Disoproxil Fumarate Tablets IP 300Mg – GENTUZA 300 Tablets

• Dual Spectrum Efficacy – Acts against both HIV-1 and HBV infections.
• Proven Clinical Effectiveness – Significantly reduces viral replication and enhances immune recovery.
• Globally Recommended First-Line Agent – Trusted by treatment guidelines for HIV and HBV management.
• Once-Daily Convenience – Enhances patient compliance and overall treatment success.

Can be Prescribed by:

• Hepatology & Gastroenterology
• HIV Specialists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.